Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2021-05-13 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-05-13 English
News release - French.pdf
Regulatory Filings
2021-05-11 English
News release - English.pdf
Investor Presentation Classification · 95% confidence The document is a press release announcing Devonian Health Group Inc.'s participation in a virtual non-deal roadshow hosted by Renmark Financial Communications. It describes the event details, speakers, and registration information. There is no actual financial data, report content, or detailed presentation included in the text. The document serves as an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, it fits best under the category of Investor Presentation (IP) as it focuses on promoting and informing about an investor-focused presentation event.
2021-05-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Devonian Health Group Inc. has retained Renmark Financial Communications Inc. to provide investor relations services. It contains no financial statements, no regulatory filings, no voting results, no management or board changes, no earnings data, and no detailed report content. It is a corporate announcement about a service engagement related to investor relations. The document length is 4702 characters, which is relatively short and consistent with a press release. There is no indication that this is a report or a filing of financial data or governance information. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2021-04-14 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Groupe Santé Devonian Inc. has selected Renmark Financial Communications Inc. to manage its investor relations activities. It contains no financial statements, no detailed financial data, no regulatory filings, no voting results, no management or board changes, no earnings information, and no report attachments. It is essentially a corporate announcement about investor relations services engagement. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-04-14 English
News release - English.pdf
Regulatory Filings
2021-03-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.